Extract Labs, a Boulder, Colorado-based hemp extraction lab, recently announced it's funding cancer research being conducted at Colorado State University, at the James L. Voss Veterinary Teaching Hospital.
Specifically, researchers at CSU are conducting lab-based research on the impact of CBD against canine glioma, or brain and spinal cancer, cells. The research began in early 2019 to learn how CBD interacts with cancer cells, alone and in combination with a commonly used radiation therapy mechanism.
CBD has been shown to possess anti-tumor effects in human and rodent gliomas, and several studies demonstrate a similarity in canine and human gliomas. The initial phase of research is almost complete, and the team at Colorado State University hopes to publish study results within the next year.
“We are proud to be one of the few CBD companies in America currently funding canine cancer research through a university that is world-renowned for its medical care and research,” said Craig Henderson, founder of Extract Labs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!